Adherence to clotting factor treatment among patients with haemophilia A or B

被引：0
|
作者：
Armstrong, P. E. [1 ]
Malone, D. C. [1 ]
Krishnon, S. [2 ]
Wessler, J. [3 ]
机构：
[1] Strateg Therapeut LLC, Tucson, AZ USA
[2] Biogen Idec Inc, Toronto, NS, Canada
[3] Naval Med Ctr, Portsmouth, VA USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：534 / 535
页数：2
相关论文
共 50 条
  • [21] Endogenous clotting factor activity and long-term outcome in patients with moderate haemophilia
    Fischer, K
    van der Bom, JG
    Mauser-Bunschoten, EP
    Roosendaal, G
    Beek, FJA
    de Kleijn, P
    Grobbee, DE
    van den Berg, HM
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (06) : 977 - 980
  • [22] Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention
    Mokhtar, Fadzlin Mohd
    Sathar, Jameela
    Huri, Hasniza Zaman
    HEALTHCARE, 2021, 9 (12)
  • [23] The characteristics and treatment patterns in haemophilia B patients receiving recombinant coagulation factor IX
    Park, Young Shil
    Hwang, Tai Ju
    Park, Sang Kyu
    Choi, Eun Jin
    Park, Jeong A.
    Baek, Hee Jo
    Lyu, Chuhl Joo
    Lee, Jae Hee
    Kim, Mi Kyung
    Kim, Ji Yoon
    Lee, Sun Ah
    Park, Boram
    Kim, Da-Hye
    Chung, Sung Beom
    Nam, Chung-Mo
    Lee, Yaeji
    Yoo, Ki Young
    HAEMOPHILIA, 2024, 30 : 134 - 136
  • [24] A regional redistribution programme for the optimal management of clotting factor concentrates prescribed by haemophilia treatment centres
    Crymble, S.
    Anderson, M.
    Travas, A.
    Floros, G.
    Teitel, J.
    TRANSFUSION MEDICINE, 2013, 23 (05) : 370 - 372
  • [25] Prophylactic treatment of patients with haemophilia A or haernophilia B
    Engelfriet, CP
    Reesink, HW
    VOX SANGUINIS, 2005, 88 (01) : 62 - 67
  • [26] Treatment strategy and outcomes among US haemophilia B patients: results of a patient survey
    Krishnan, S.
    Furlan, R.
    Vietri, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1088 - 1088
  • [27] Association of adherence to prophylaxis treatment with bleeding frequency and comorbidity among haemophilia patient
    Sathar, Jameela
    Mokhtar, Fadzlin Mohd
    HAEMOPHILIA, 2020, 26 : 83 - 83
  • [28] Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A
    Novembrino, Cristina
    Anzoletti, Massimo Boscolo
    Mancuso, Maria Elisa
    Shinohara, Sho
    Peyvandi, Flora
    HAEMOPHILIA, 2019, 25 (03) : 521 - 526
  • [29] Evaluation of clotting factor consumption and its determinants in a population of adult haemophilia patients from Belgium
    Hermans, C.
    Barros E Carvalhosa, A. Monteiro
    Henrard, S.
    HAEMOPHILIA, 2012, 18 : 20 - 21
  • [30] TREATMENT OF HEMOPHILIA B WITH A NEW CLOTTING-FACTOR CONCENTRATE
    HOAG, S
    JOHNSON, FF
    ROBINSON, JA
    AGGELER, PM
    NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (11): : 581 - &
12345